Diabetes is a serious disease, but the risk of long-term complications can be reduced by controlling blood sugar levels with medicines. In recent years, new and effective medicines have helped people living with diabetes. However, these medicines cost $57.6 billion per year in the United States. This is about 15-20% of the yearly cost for all prescription drugs. The financial burden has a devastating impact on people without health insurance and on people with high deductibles — these are the people least able to afford the high cost of diabetes drugs. Expensive diabetes drugs impact both public policy and social justice. Fortunately, after new diabetes drugs lose their patent protection, other manufacturers can create cheaper (generic) versions. However, this can take many years. If the U.S. wishes to promote health care equity and social justice, the cost of diabetes drugs must be reduced.